Login to Your Account

GlobeImmune, Celgene Form $540M Cancer Partnership

By Catherine Hollingsworth

Monday, May 18, 2009
Celgene Corp. will pay GlobeImmune Inc. $40 million up-front to gain access to all of the company's cancer drug programs. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription